Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Pliant Therapeutics (PLRX) Non Operating Income (2019 - 2020)

Pliant Therapeutics (PLRX) has disclosed Non Operating Income for 2 consecutive years, with -$97000.0 as the latest value for Q4 2020.

  • On a quarterly basis, Non Operating Income changed N/A to -$97000.0 in Q4 2020 year-over-year; TTM through Dec 2020 was -$104000.0, a N/A change, with the full-year FY2020 number at -$366000.0, down 69.44% from a year prior.
  • Non Operating Income was -$97000.0 for Q4 2020 at Pliant Therapeutics, down from $55000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $55000.0 in Q3 2020 to a low of -$97000.0 in Q4 2020.